Clinica
Geron, Angiotech exit stem cell arena as funds dry up, but good news for Mesoblast
15 November 2011
Madeleine Armstrong
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- S Korea forges ahead in stem cells as Medipost preps for first allogeneic therapy launch
- StemCells gets FDA nod for dry AMD trial using neural stem cells
- US Capitol Capsule: Court rulings in gene patent, stem cell cases provide new hope for medtech
- South Korea grants first approval worldwide to a stem cell therapy
Other Informa News
EVENTS
